Table 1:
Group | Age | Sex | EF | Type | Tissue Origin | NYHA Class |
---|---|---|---|---|---|---|
Non-Failing | 31 | Male | 60% | NA | RV from Lead | I |
Non-Failing | 62 | Female | >60% | NA | RV from Lead | I |
Failing | 70 | Male | 20% | ICM | RV from Lead | III |
Failing | 59 | Male | 20% | NICM- Sarcoidosis | RV from Lead | II |
Non-Failing | 65 | Male | >60% | NA | RV from Explant | I |
Failing | 63 | Female | 21% | NICM-Myocarditis | RV from Explant | II |
Failing | 49 | Male | 15% | ICM | RV from Explant | III |
Failing | 64 | Male | 23% | ICM | RV from Explant | IV |
Failing | 43 | Male | 25% | ICM | RV from Explant | III |